17-alpha-hydroxyprogesterone caproate and natural progesterone in assisted reproduction: A comparative study

Clinical and Experimental Obstetrics and Gynecology

Volumn 24, Issue 4, 1997, Pages 190-192

  Abate, A ^a   Brigandi A ^a   Costabile, L ^b,c   Abate, F G ^a   Balzano, E ^b   Perino, M ^a  

^a Papardo Hospital   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL;

ADULT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; HYDROXYPROGESTERONES; PREGNANCY; PROGESTERONE; PROGESTERONE CONGENERS;

EID: 0031440009     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Csapo A. I., Pulkkinen M. O., Ruttner B., Sauvage J. P., Wiest W. G.: "The significance of human corpus luteum in pregnancy maintenance". Am. J. Obstet. Gynecol., 1972, 112, 1061.
2. Li T. C., Cooke L. D.: "Evaluation of luteal phase". Hum. Reprod.I, 1991, 6, 484.
3. Jones G. S.: "The luteal phase defect". Fertil. Steril., 1975, 27, 351.
4. Huang K. E., Mucchler E. K., Schwartz F. K., Goggin M., Graham M.: "Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization". Fertil. Steril., 1986, 46, 903.
5. Smith E. M., Anthony F. W., Gadd S. C., Masson G. M.: "Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausa gonadotropin in women taking part in an in vitro fertilization programme". Br. Med. J., 1989, 298, 1483.
6. Belaisch-Allart J., De Mouzon J., Lapouterle C., Mayer M.: "The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme". Hum. Reprod., 1990, 5, 163.
7. Weckstein L. N., Jacobson A., Galen D., Hampton K., Ivani K., Andres J.: "Improvement of pregnancy rates with oocyte donation in older recipients with the addition of progesterone vaginal suppositories". Fertil. Steril., 1993, 60, 573.
8. Michalas S., Loutradis, Drakakis P., Kallianidis K., Milingos S., Deligeoroglou E., Aravantinos D.: "A flexible protocol for the induction of recipient endometrial cycles in an oocyte donation programme". Hum. Reprod., 1996, 11, 1063.
9. Lin Y. P., Cassidenti D. L., Chacon R. R., Soubra S. S., Rosen G. F., Yee B.: "Successful implantation of frozen sibling embryos is influenced by the outcome of the cycle from which they were derived". Comment in: Fertil. Steril, 1995, 64, 1046.
10. Stovall D. W., Van Voorhis B. J., Mattingly K. L., Sparks A. E., Chapler F. K., Sirop C. H.: "The effectiveness of sublingual progesterone administration during cryopreserved embryo transfer cycles: results of a matched follow up study". Fertil. Steril., 1996, 65, 986.
11. Lelaidier C., de Ziegler D., Freitas S., Olivennes F., Hazout A., Frydman: "Endometrium preparation with exogenous estradiol and progesterone for the transfer of cryopreserved blastocystis". Fertil. Steril., 1995, 63, 919.
12. Li T. C., Warren M. A., Cooke I. D.: "The artificial cycle as an effective treatment retarded endometrium in the luteal phase". Hum. Reprod., 1994, 9, 409.
13. Ben Nun I., Siegal A., Shulman A., Ghetler Y., Kaneti H., Lununfeld B., Beyth Y., Fejgin M.: "Induction of artificial endometrial cycles with oestradiol implants and injectable progesterone: establishment of a viable pregnancy in a woman with 17-alpha-hydroxylase deficiency". Hum. Reprod., 1995, 10, 2456.
14. Castelazo Ayala L., Espinosa De Los Reyes V., Gonzales Ramos M., Reyes Ceja L.: "Efectos del capronato de 17-alfa-oxiprogesterone en 100 casos de amenaza de aborto". Ginec. Y. Obstet. Mex., 1959, XIV, 249.
15. Daya S., Ward S., Burrows E.: "Progesterone profiles in luteal phase defect cacles and anteone of progesterone treatment in patients with recurrent spontaneous abortion". Am. I. Obstet. Gynecol, 1988, 158, 255.
16. Hirvonen E.: "Progestins". Maturitas, 1996, 23 Suppl., 13.
17. Urlich U., Pfeifer T., Lauritzen C.: "Rapid increase in lumbar spine bone density in osteopenic women by high-dose intramuscular estrogen-progestogen injections". Horm. Metabol. Res., 1994, 26 (9), 428.
18. Leeton J., Trounson A., Jessup D.: "Support of luteal phase in vitro fertilization programs: results of a controlled trial with intramuscular proluton". J. in Vitro Fert. Embryo Transf., 1985, 2, 166.
19. Van Steirteghem A. C., Smitz J., Camus M., Van Waesberghe L., Descharcht J., Khan I., et al.: "The luteal phase after in-vitro fertilization and related procedures". Human. Reprod., 1988, 3, 161.
20. Wong Y. F.: "Loong E. P. L., Mao K. R., Tam P. L., Panesur N. S., Neale E., et al: "Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens". Reprod. Fertil. Dev., 1990, 2, 351.
21. Soliman S., Daya S., Collins J., Hughes E. G.: "The role of luteal phase support in infertility treatment: a metaanalysis of randomized trials". Fertil. Steril., 1994, 61, 1068.